BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 14651806)

  • 1. Treatment with vitamin B3 improves functional recovery and reduces GFAP expression following traumatic brain injury in rats.
    Hoane MR; Akstulewicz SL; Toppen J
    J Neurotrauma; 2003 Nov; 20(11):1189-99. PubMed ID: 14651806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Administration of riboflavin improves behavioral outcome and reduces edema formation and glial fibrillary acidic protein expression after traumatic brain injury.
    Hoane MR; Wolyniak JG; Akstulewicz SL
    J Neurotrauma; 2005 Oct; 22(10):1112-22. PubMed ID: 16238487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with magnesium improves reference memory but not working memory while reducing GFAP expression following traumatic brain injury.
    Hoane MR
    Restor Neurol Neurosci; 2005; 23(2):67-77. PubMed ID: 15990413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Middle age increases tissue vulnerability and impairs sensorimotor and cognitive recovery following traumatic brain injury in the rat.
    Hoane MR; Lasley LA; Akstulewicz SL
    Behav Brain Res; 2004 Aug; 153(1):189-97. PubMed ID: 15219720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotinamide treatment reduces behavioral impairments and provides cortical protection after fluid percussion injury in the rat.
    Hoane MR; Tan AA; Pierce JL; Anderson GD; Smith DC
    J Neurotrauma; 2006 Oct; 23(10):1535-48. PubMed ID: 17020488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The novel apolipoprotein E-based peptide COG1410 improves sensorimotor performance and reduces injury magnitude following cortical contusion injury.
    Hoane MR; Pierce JL; Holland MA; Birky ND; Dang T; Vitek MP; McKenna SE
    J Neurotrauma; 2007 Jul; 24(7):1108-18. PubMed ID: 17610351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicotinamide reduces acute cortical neuronal death and edema in the traumatically injured brain.
    Hoane MR; Gilbert DR; Holland MA; Pierce JL
    Neurosci Lett; 2006 Nov; 408(1):35-9. PubMed ID: 16987607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical efficacy testing in middle-aged rats: nicotinamide, a novel neuroprotectant, demonstrates diminished preclinical efficacy after controlled cortical impact.
    Swan AA; Chandrashekar R; Beare J; Hoane MR
    J Neurotrauma; 2011 Mar; 28(3):431-40. PubMed ID: 21083416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicotinamide treatment provides acute neuroprotection and GFAP regulation following fluid percussion injury.
    Holland MA; Tan AA; Smith DC; Hoane MR
    J Neurotrauma; 2008 Feb; 25(2):140-52. PubMed ID: 18260797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Administration of raloxifene reduces sensorimotor and working memory deficits following traumatic brain injury.
    Kokiko ON; Murashov AK; Hoane MR
    Behav Brain Res; 2006 Jun; 170(2):233-40. PubMed ID: 16580743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnesium and riboflavin combination therapy following cortical contusion injury in the rat.
    Barbre AB; Hoane MR
    Brain Res Bull; 2006 May; 69(6):639-46. PubMed ID: 16716831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicotinamide treatment induces behavioral recovery when administered up to 4 hours following cortical contusion injury in the rat.
    Hoane MR; Pierce JL; Holland MA; Anderson GD
    Neuroscience; 2008 Jun; 154(3):861-8. PubMed ID: 18514428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous nicotinamide administration improves behavioral recovery and reduces lesion size following bilateral frontal controlled cortical impact injury.
    Vonder Haar C; Anderson GD; Hoane MR
    Behav Brain Res; 2011 Oct; 224(2):311-7. PubMed ID: 21704653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The behavioral effects of magnesium therapy on recovery of function following bilateral anterior medial cortex lesions in the rat.
    Hoane MR; Knotts AA; Akstulewicz SL; Aquilano M; Means LW
    Brain Res Bull; 2003 Apr; 60(1-2):105-14. PubMed ID: 12725898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COG1410 improves cognitive performance and reduces cortical neuronal loss in the traumatically injured brain.
    Hoane MR; Kaufman N; Vitek MP; McKenna SE
    J Neurotrauma; 2009 Jan; 26(1):121-9. PubMed ID: 19119914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postinjury administration of L-deprenyl improves cognitive function and enhances neuroplasticity after traumatic brain injury.
    Zhu J; Hamm RJ; Reeves TM; Povlishock JT; Phillips LL
    Exp Neurol; 2000 Nov; 166(1):136-52. PubMed ID: 11031090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tapered progesterone withdrawal promotes long-term recovery following brain trauma.
    Cutler SM; Vanlandingham JW; Stein DG
    Exp Neurol; 2006 Aug; 200(2):378-85. PubMed ID: 16797538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etifoxine improves sensorimotor deficits and reduces glial activation, neuronal degeneration, and neuroinflammation in a rat model of traumatic brain injury.
    Simon-O'Brien E; Gauthier D; Riban V; Verleye M
    J Neuroinflammation; 2016 Aug; 13(1):203. PubMed ID: 27565146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of chronic, post-injury Cyclosporin A administration on motor and sensorimotor function following severe, experimental traumatic brain injury.
    Riess P; Bareyre FM; Saatman KE; Cheney JA; Lifshitz J; Raghupathi R; Grady MS; Neugebauer E; McIntosh TK
    Restor Neurol Neurosci; 2001; 18(1):1-8. PubMed ID: 11673665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic folic acid administration confers no treatment effects in either a high or low dose following unilateral controlled cortical impact injury in the rat.
    Vonder Haar C; Emery MA; Hoane MR
    Restor Neurol Neurosci; 2012; 30(4):291-302. PubMed ID: 22572023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.